Yangyang Li

Ms. Yangyang Li


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YQYafeng Qi
Yafeng Qi
ZLZhang Liying
Zhang Liying
YLYeyuan Liu
Yeyuan Liu
YLYangyang Li
Yangyang Li
LYLiu Yongqi
Liu Yongqi
ZZzhiming zhang
zhiming zhang
Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous population of immature myeloid cells originating from the bone marrow, known for their potent immunosuppressive functions that contribute to tumor immune evasion and progression. This paper provides a comprehensive analysis of the multifaceted interactions between MDSCs and tumors, exploring their distinct phenotypes and immunosuppressive mechanisms. Key roles of MDSCs in tumor biology are discussed, including their involvement in the formation of the pre-metastatic niche, facilitation of angiogenesis, enhancement of vascular permeability, suppression of tumor cell apoptosis, and promotion of resistance to cancer therapies. Additionally, the review highlights recent advances in the development of MDSC-targeting therapies, with a focus on their potential to enhance anti-tumor immunity. The therapeutic potential of Traditional Chinese Medicine (TCM) in modulating MDSC quantity and function is also explored, suggesting a novel approach to cancer treatment by integrating traditional and modern therapeutic strategies.

20 June 2023 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
LSLiangliang Shi
Liangliang Shi
SWShuaizhe Wang
Shuaizhe Wang
SZShangzu Zhang
Shangzu Zhang
JWJiawei Wang
Jiawei Wang
YCYaping Chen
Yaping Chen
ZLZhang Liying
Zhang Liying